1Vanhoutte, PM, Shimokawa, H, Tang, EH, et al. (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196, 193–222.
2Vita, JA (2003) Tea consumption and cardiovascular disease: effects on endothelial function. J Nutr 133, 3293S–3297S.
3Ras, RT, Zock, PL & Draijer, R (2011) Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis. PLoS One 6, e16974.
4Coimbra, SR, Lage, SH, Brandizzi, L, et al. (2005) The action of red wine and purple grape juice on vascular reactivity is independent of plasma lipids in hypercholesterolemic patients. Braz J Med Biol Res 38, 1339–1347.
5Andrade, AC, Cesena, FH, Consolim-Colombo, FM, et al. (2009) Short-term red wine consumption promotes differential effects on plasma levels of high-density lipoprotein cholesterol, sympathetic activity, and endothelial function in hypercholesterolemic, hypertensive, and healthy subjects. Clinics (Sao Paulo) 64, 435–442.
6Fisher, ND, Hughes, M, Gerhard-Herman, M, et al. (2003) Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 21, 2281–2286.
7Heiss, C, Dejam, A, Kleinbongard, P, et al. (2003) Vascular effects of cocoa rich in flavan-3-ols. JAMA 290, 1030–1031.
8Engler, MB, Engler, MM, Chen, CY, et al. (2004) Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23, 197–204.
9Farouque, HM, Leung, M, Hope, SA, et al. (2006) Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin Sci (Lond) 111, 71–80.
10Heiss, C, Finis, D, Kleinbongard, P, et al. (2007) Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol Ther 49, 74–80.
11Balzer, J, Rassaf, T, Heiss, C, et al. (2008) Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients: a double-masked, randomized, controlled trial. J Am Coll Cardiol 51, 2141–2149.
12Monahan, KD, Feehan, RP, Kunselman, AR, et al. (2011) Dose-dependent increases in flow-mediated dilation following acute cocoa ingestion in healthy older adults. J Appl Physiol 111, 1568–1574.
13Njike, VY, Faridi, Z, Shuval, K, et al. (2011) Effects of sugar-sweetened and sugar-free cocoa on endothelial function in overweight adults. Int J Cardiol 149, 83–88.
14Shrime, MG, Bauer, SR, McDonald, AC, et al. (2011) Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr 141, 1982–1988.
15Vlachopoulos, C, Aznaouridis, K, Alexopoulos, N, et al. (2005) Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 18, 785–791.
16Schroeter, H, Heiss, C, Balzer, J, et al. (2006) Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 103, 1024–1029.
17Faridi, Z, Njike, VY, Dutta, S, et al. (2008) Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr 88, 58–63.
18Davison, K, Coates, AM, Buckley, JD, et al. (2008) Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes 32, 1289–1296.
19Knorr, M, Hausding, M, Kroller-Schuhmacher, S, et al. (2011) Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan. Arterioscler Thromb Vasc Biol 31, 2223–2231.
20Vlachopoulos, CV, Alexopoulos, NA, Aznaouridis, KA, et al. (2007) Relation of habitual cocoa consumption to aortic stiffness and wave reflections, and to central hemodynamics in healthy individuals. Am J Cardiol 99, 1473–1475.
21Nichols, WW & Epstein, BJ (2009) Actions of selected cardiovascular hormones on arterial stiffness and wave reflections. Curr Pharm Des 15, 304–320.
22Payne, M, Hurst, W, Stuart, D, et al. (2010) Determination of total procyanidins in selected chocolate and confectionery products using DMAC. J AOAC Int 93, 89–96.
23Heffernan, KS, Kuvin, JT, Sarnak, MJ, et al. (2011) Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 26, 2515–2521.
24Patvardhan, E, Heffernan, KS, Ruan, J, et al. (2011) Augmentation index derived from peripheral arterial tonometry correlates with cardiovascular risk factors. Cardiol Res Pract 2011, 253758.
25Recio-Rodriguez, JI, Gomez-Marcos, MA, Patino-Alonso, MC, et al. (2012) Cocoa intake and arterial stiffness in subjects with cardiovascular risk factors. Nutr J 11, 8.
26Ou, B, Hampsch-Woodill, M & Prior, RL (2001) Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem 49, 4619–4626.
27Huang, D, Ou, B, Hampsch-Woodill, M, et al. (2002) Development and validation of oxygen radical absorbance capacity assay for lipophilic antioxidants using randomly methylated beta-cyclodextrin as the solubility enhancer. J Agric Food Chem 50, 1815–1821.
28Singleton, VL & Rossi, JA (1965) Colorimetry of total phenolics with phosphomolybdic–phosphotungstic acid reagents. Am J Enol Vitic 16, 144–158.
29Nelson, BC & Sharpless, KE (2003) Quantification of the predominant monomeric catechins in baking chocolate standard reference material by LC/APCI-MS. J Agric Food Chem 51, 531–537.
30Hurst, W, Stanley, B, Glinski, J, et al. (2009) Characterization of primary standards for use in the HPLC analysis of the procyanidin content of cocoa and chocolate containing products. Molecules 14, 4136–4146.
31Robbins, RJ, Leonczak, J, Johnson, JC, et al. (2009) Method performance and multi-laboratory assessment of a normal phase high pressure liquid chromatography-fluorescence detection method for the quantitation of flavanols and procyanidins in cocoa and chocolate containing samples. J Chroma A 1216, 4831–4840.
32Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Health and Nutrition Examination Survey Data & Hyattsville MUSDoH (1994) Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Series 1: programs and collection procedures. Vital Health Stat 1, 1–407.
33Baba, S, Osakabe, N, Yasuda, A, et al. (2000) Bioavailability of ( − )-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radic Res 33, 635–641.
34Celermajer, DS, Sorensen, KE, Gooch, VM, et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340, 1111–1115.
35West, SG, Wagner, P, Schoemer, SL, et al. (2004) Biological correlates of day-to-day variation in flow-mediated dilation in individuals with type 2 diabetes: a study of test–retest reliability. Diabetologia 47, 1625–1631.
36West, SG, Hecker, KD, Mustad, VA, et al. (2005) Acute effects of monounsaturated fatty acids with and without omega-3 fatty acids on vascular reactivity in individuals with type 2 diabetes. Diabetologia 48, 113–122.
37Bonetti, PO, Pumper, GM, Higano, ST, et al. (2004) Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 44, 2137–2141.
38McCrea, CE, Skulas-Ray, AC, Chow, M, et al. (2012) Test–retest reliability of pulse amplitude tonometry measures of vascular endothelial function: implications for clinical trial design. Vasc Med 17, 29–36.
39Rubinshtein, R, Kuvin, JT, Soffler, M, et al. (2010) Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 31, 1142–1148.
40Hamburg, N, Keyes, M & Larson, M (2008) Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 117, 2467–2474.
41Hamburg, NM & Benjamin, EJ (2009) Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med 19, 6–11.
42Wilkinson, IB, MacCallum, H, Flint, L, et al. (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525, 263–270.
43Persson, IA, Persson, K, Hagg, S, et al. (2011) Effects of cocoa extract and dark chocolate on angiotensin-converting enzyme and nitric oxide in human endothelial cells and healthy volunteers – a nutrigenomics perspective. J Cardiovasc Pharmacol 57, 44–50.
44Morgan, C & Lazarow, A (1963) Immunoassay of insulin: two antibody system. Plasma insulin levels in normal, subdiabetic, and diabetic rats. Diabetes 12, 115–126.
45Bonora, E, Formentini, G, Calcaterra, F, et al. (2002) HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25, 1135–1141.
46Hooper, L, Kroon, PA, Rimm, EB, et al. (2008) Flavonoids, flavonoid rich foods, and cardiovascular risk: a meta analysis of randomized trials. Am J Clin Nutr 88, 38–50.
47Karim, M, McCormick, K & Kappagoda, CT (2000) Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr 130, 2105S–2108S.
48Schnorr, O, Brossette, T, Momma, TY, et al. (2008) Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch Biochem Biophys 476, 211–215.
49Ottaviani, JI, Momma, TY, Heiss, C, et al. (2011) The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radic Biol Med 50, 237–244.
50Loke, WM, Hodgson, JM, Proudfoot, JM, et al. (2008) Pure dietary flavonoids quercetin and ( − )-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88, 1018–1025.
51Heiss, C, Kleinbongard, P, Dejam, A, et al. (2005) Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 46, 1276–1283.
52Fisher, ND & Hollenberg, NK (2006) Aging and vascular responses to flavanol-rich cocoa. J Hypertens 24, 1575–1580.
53Crews, WD Jr, Harrison, DW & Wright, JW (2008) A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr 87, 872–880.
54Ried, K, Sullivan, T, Fakler, P, et al. (2010) Does chocolate reduce blood pressure? A meta-analysis. BMC Med 8, 39.
55Grassi, D, Necozione, S, Lippi, C, et al. (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46, 398–405.
56Grassi, D, Desideri, G, Necozione, S, et al. (2008) Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr 138, 1671–1676.
57Berry, NM, Davison, K, Coates, AM, et al. (2010) Impact of cocoa flavanol consumption on blood pressure responsivenes to exercise. Br J Nutr 103, 1480–1484.
58Gosmanov, AR, Smiley, DD, Robalino, G, et al. (2010) Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Phys Endocrinol Metab 299, E953–E958.
59Hooper, L, Kay, C, Abdelhamid, A, et al. (2012) Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 95, 740–751.